天瑞儀器(300165.SZ):收購磐合科儀37.0265%股權已完成過户手續
格隆匯 9 月 21日丨天瑞儀器(300165.SZ)公佈,公司通過發行股份的方式購買趙學偉、王宏等36名股東持有的上海磐合科學儀器股份有限公司(“磐合科儀”)37.0265%股權並募集配套資金事項已取得中國證監會核准。截至公告披露日,此次交易涉及的標的資產已完成過户手續。磐合科儀已出具相應的《股東名冊》,並向公司簽發了《出資證明書》。截止公告發布之日,公司持有磐合科儀99.4517%股份,標的資產過户手續已完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.